Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. (65/194)

 (+info)

Conformity of commercial oral single solid unit dose packages in hospital pharmacy practice. (66/194)

 (+info)

Adsorption of (99m)Tc-radiopharmaceuticals onto injection vials and syringes. (67/194)

 (+info)

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study. (68/194)

 (+info)

Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700,000 elderly. (69/194)

 (+info)

Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination. (70/194)

 (+info)

Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. (71/194)

In April 2008, the Centers for Medicare and Medicaid Services (CMS) published in the Federal Register its final rule on Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities. The rule establishes new conditions dialysis facilities must meet to be certified under the Medicare program and is intended to update CMS standards for delivery of quality care to dialysis patients. CDC's 2001 Recommendations for Preventing Transmission of Infections among Chronic Hemodialysis Patients have been incorporated by reference into the new CMS conditions for coverage. Thus, effective October 14, 2008, all ESRD facilities are expected to follow the CDC recommendations as a condition for receiving Medicare payment for outpatient dialysis services.  (+info)

Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. (72/194)

 (+info)